Comment contacter le centre
Centre de soins de santé
L'histoire du Rigshospitalet remonte au premier véritable hôpital du Danemark, « l'hôpital Royal Frederiks », qui a été créé pour soigner et traiter les pauvres Copenhague par attachement. L'hôpital a ouvert ses portes en 1757 et était situé à Bredgade, où se trouve aujourd'hui le Kunstindustrimuseet. En 1910, l'hôpital est devenu partie intégrante de l'État et a déménagé à son emplacement actuel, à Blegdamsvej. L'hôpital a également changé son nom pour Rigshospitalet, car il devrait à l'avenir être accessible à tous les citoyens du Royaume. Le Rigshospital moderne, avec ses grands bâtiments gris, date des années 1960 et fait aujourd'hui partie de la région de la capitale.
Photo : Ole Morten Nygård
Contact
Rigshospitalet, Copenhagen, Denmark
équipe
Dr Steffen HAMANN
Danemark
Pr Michael LARSEN
Danemark
Line Kessel
Danemark
Essais cliniques
A Phase 3, Randomized, International Multicenter Trial of DAY101 Monotherapy Versus Standard of Care Chemotherapy in Patients with Pediatric Low-Grade Glioma Harboring an Activating RAF Alteration Requiring First-Line Systemic Therapy
TENecteplase in Central Retinal Artery Occlusion Study (TenCRAOS): A Randomized Placebo-controlled Trial of Early Systemic Tenecteplase Treatment in Patients With Central Retinal Artery Occlusion.
This is a single-arm open label interventional safety trial with RP patients, who receive weekly TES for 6 months on 1 eye followed by observation for another 6 months without stimulation. The primary outcome measure is safety, indicated by the frequency and severity of adverse events.
Natural history of patients with inherited retinal diseases due to mutations in RPE65 gene
Safety and Efficacy of Emixustat in Stargardt Disease.
Efficacy and safety of QLT091001 in subjects with Inherited Retinal Disease (IRD) caused by gene mutations.
A Long-term Follow-up Study to Evaluate the Safety and efficacy of Retinal Gene Therapy in Subjects with choroideremia treated previously with Adeno-Associated Viral Vector Encoding Rab Escort Protein-1 (AAV2-REP1) in an Antecedent Study.
A Non-interventional Study of Clinical Experience in Patients Prescribed Raxone® for the Treatment of Leber’s Hereditary Optic Neuropathy (LHON).
Natural History Study in Inherited Retinal Disease Subjects Caused by Mutations in RPE65 or LRAT.
Clinical and Genetic Examination of Usher Syndrome Patients’ Cohort in Europe.
A Phase 2b, Randomized, Double-masked, Multicenter, Dose-ranging, Sham-controlled Clinical Trial to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Advanced Characterization of Autosomal Dominant Optic Atrophy.
Transcorneal Electrical Stimulation - Multicenter Safety Study.
Identification and Verification of Candidate Genes Responsible for Optic Disc Drusen
Non-Arteritic Anterior Ischemic Optic Neuropathy Risk Factors: New Perspectives
A Head-to-head Comparison of Ultrasound Versus Temporal Artery Biopsy in the Diagnosis of Giant Cell Arteritis
Global Patient Registry of Inherited Retinal Disease